bi-layer calcium carbonate tablet (BAY1180654) + Immediate release calcium carbonate tablet (BAY1180654)
Phase 1Completed 0 watching 0 views this week💤 Quiet
30
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Heartburn
Conditions
Heartburn, Indigestion, Stomach Acid Related Symptoms, Nocturnal Stomach Acid Related Symptoms, Healthy Volunteers
Trial Timeline
Mar 6, 2024 → May 15, 2024
NCT ID
NCT06293326About bi-layer calcium carbonate tablet (BAY1180654) + Immediate release calcium carbonate tablet (BAY1180654)
bi-layer calcium carbonate tablet (BAY1180654) + Immediate release calcium carbonate tablet (BAY1180654) is a phase 1 stage product being developed by Bayer for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT06293326. Target conditions include Heartburn, Indigestion, Stomach Acid Related Symptoms.
Hype Score Breakdown
Clinical
10
Activity
5
Company
7
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06293326 | Phase 1 | Completed |
Competing Products
20 competing products in Heartburn